477 related articles for article (PubMed ID: 8247550)
1. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
[TBL] [Abstract][Full Text] [Related]
2. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.
Zhang YJ; Jiang W; Chen CJ; Lee CS; Kahn SM; Santella RM; Weinstein IB
Biochem Biophys Res Commun; 1993 Oct; 196(2):1010-6. PubMed ID: 8240318
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cell cycle entry and G1 progression by CSF-1.
Roussel MF
Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
[TBL] [Abstract][Full Text] [Related]
4. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
Lovec H; Sewing A; Lucibello FC; Müller R; Möröy T
Oncogene; 1994 Jan; 9(1):323-6. PubMed ID: 8302597
[TBL] [Abstract][Full Text] [Related]
6. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
Bartkova J; Lukas J; Müller H; Strauss M; Gusterson B; Bartek J
Cancer Res; 1995 Feb; 55(4):949-56. PubMed ID: 7850812
[TBL] [Abstract][Full Text] [Related]
7. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein.
Bartkova J; Lukas J; Strauss M; Bartek J
J Pathol; 1994 Mar; 172(3):237-45. PubMed ID: 8195927
[TBL] [Abstract][Full Text] [Related]
9. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
[TBL] [Abstract][Full Text] [Related]
12. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells.
Zhou P; Jiang W; Zhang YJ; Kahn SM; Schieren I; Santella RM; Weinstein IB
Oncogene; 1995 Aug; 11(3):571-80. PubMed ID: 7630641
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 as a cellular proto-oncogene.
Bates S; Peters G
Semin Cancer Biol; 1995 Apr; 6(2):73-82. PubMed ID: 7647309
[TBL] [Abstract][Full Text] [Related]
14. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.
Gillett C; Fantl V; Smith R; Fisher C; Bartek J; Dickson C; Barnes D; Peters G
Cancer Res; 1994 Apr; 54(7):1812-7. PubMed ID: 8137296
[TBL] [Abstract][Full Text] [Related]
15. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control.
Lukas J; Aagaard L; Strauss M; Bartek J
Cancer Res; 1995 Nov; 55(21):4818-23. PubMed ID: 7585513
[TBL] [Abstract][Full Text] [Related]
17. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
18. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma.
Nishida N; Fukuda Y; Komeda T; Kita R; Sando T; Furukawa M; Amenomori M; Shibagaki I; Nakao K; Ikenaga M
Cancer Res; 1994 Jun; 54(12):3107-10. PubMed ID: 8205525
[TBL] [Abstract][Full Text] [Related]
19. Terminal differentiation of normal chicken erythroid progenitors: shortening of G1 correlates with loss of D-cyclin/cdk4 expression and altered cell size control.
Dolznig H; Bartunek P; Nasmyth K; Müllner EW; Beug H
Cell Growth Differ; 1995 Nov; 6(11):1341-52. PubMed ID: 8562472
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cyclin D1 enhances gene amplification.
Zhou P; Jiang W; Weghorst CM; Weinstein IB
Cancer Res; 1996 Jan; 56(1):36-9. PubMed ID: 8548770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
